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Introduction 
Synthetic biology can be defined as the application of engineering principles to the 
fundamental components of biology. More precisely the UK Royal Society (Royal Society, 
s.a.) describes synthetic biology as follows:  
 
     Synthetic biology is an emerging area of research that can broadly be described as the 
design and construction of novel artificial biological pathways, organisms or devices, or 
 the redesign of existing natural biological systems. 
 
The term synthetic biology was first introduced by the French scientist Stéphane Leduc 
(1912), be it with a different meaning as today’s, and (it seems) in modern times by the Polish 
geneticist Waclaw Szybalski (1974). Putting aside priority questions it is true that the term 
gained popularity in mainstream science only in the year 2004 when the first international 
meeting, called Synthetic Biology 1.0, was held at MIT. Envisaging loads of other 
applications scientists nowadays declare that they can do better than evolution (Schuster, 
2013). Among other aspects, Schuster points to promising aspects for information storage, 
recalling a pilot study (Church et al., 2012) in which an entire book was stored on a single 
DNA molecule.  
The purpose of this investigation is to reveal the what – where - when of the current situation 
in this emerging field. In particular, we calculated “year based h-type indices” for high-
frequent keywords. 
 
Literature review 
The main article using informetric techniques to study the field of synthetic biology is 
(Oldham, Hall and Burton, 2012). They explore the field to inform debates on the governance 
(related to the United Nations Convention on Biological Diversity) of the field. For this 
reason they focus on different visualizations of the field. Based on WoS data they distinguish 
between two groups of articles: the core consisting of 1.255 publications and a group of 
articles citing the core leading to another 5.995 items. Their core was obtained by a topic 
search for “synthetic biology”, “synthetic genomics”, “synthetic genome” or “synthetic 
genomes”. Details are discussed further on when comparing their results with ours. We note 
though that Oldham et al. (2012) observed the incipient diversification of synthetic biology 
into several subspecialties. They point out that taking this diversification into account is 
important for policy debates as synthetic biology may cease to be a ‘unitary’ object for policy 
action. 
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Recently Goldman (2014) studied the related field of systems biology, using this field as an 
example to explore changes in the disciplinary structure of a field. She works under the 
assumption that concepts from systems biology are transmitted by papers linked via journals 
to various disciplines. Using a bipartite network she explores connectivity among subject 
categories and journals. Over the period 2000-2011 the number of subject categories and the 
number of journals both increased, while the percentage of subject categories with 
betweenness centrality equal to zero decreased. The whole structure can be characterized as a 
core - semi-periphery -  periphery structure. She further notes that growth at the periphery 
occurs largely through interdisciplinary journals. Her time study reveals that several clinical 
disciplines such as Immunology and Oncology move toward the core over time.  
 
Methods 
Data collection  
We employed the following methodology to obtain the data for our investigation. 
(1) Essential records were retrieved using the term “synthetic biology” as a topic search in the 
Web of Science (WoS): 
TS=”synthetic biology” and document type = article  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2000-2013 
This search retrieved 1333 records (retrieved date: Jan.11, 2014).  
(2) Next, we extracted the “Keywords” and “Keywords Plus” from all 1333 records, and 
obtained their frequencies. In this way 6054 terms were found and ranked by frequency.  
(3) We sought the precise meanings of the terms in this list making use of MeSH (Medical 
Subject Headings) definitions. This led to a list of most used content terms related specifically 
to synthetic biology (recall that one of the authors is head of the Medical Information Center 
of Zhejiang University School of Medicine, and hence is capable of making this kind of 
evaluation). 
(4) We then used these specific content terms related to synthetic biology to expand the 
original query, leading to the final search string: 
TS= ("synthetic biology " or "synthetic gene network*" or biobrick* or "protein design*" or 
"genetic circuit*" or "gene regulatory network*" or "cell-free protein synthes*” or “metabolic 
engineering" or "protein engineering” or “promoter engineering” or “DNA assembly” or 
“RNA engineering biosensors” or “multipart DNA assembly” or “sequential circuits” or 
“benchmark synthetic circuits” or “DNA nanotechnology” or “human artificial chromosome” 
or “synthetic promoters” or “transcriptional circuits” or “abstract genetic regulatory 
network*” or “gene assembly” or “post-transcriptional regulation” or “engineered proteins”   
or “cell-free gene circuits”) AND Document Types=(Article) 
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2000-2013 
 
In this way, 13,836 records were obtained (retrieved date:  Jan.15, 2014). This is the set 
discussed in this article. We note that Goldman (2014) only used the topic search term 
“systems biology” and included all publication types, leading to 4,446 publications over the 
period 2000 through 2011. 
 
As “synthetic biology” is said to hold great promise for commercialization we also performed 
a search for patents in the Derwent Innovations Index (DII), using a similar search query as in 
the WoS. The search was performed on January 24, 2014 and this for the Timespan=2000-
2013. This resulted in 788 patent records. 
 
 
 
Data processing 
(1) Topic keyword counting. We determined the keyword frequency based on the retrieved 
13,836 records, and their yearly distribution. 
(2) Dynamical changes in keyword use. To find out dynamical changes over the period 2000-
2013, we calculated “year based h-type indices” for the high-frequent keywords (Mahbuba & 
Rousseau, 2013). 
 
Basic results 
In this section we show basic results: most active countries/regions and organizations; WoS 
categories and areas to which articles on synthetic biology belong; number of articles per year 
and growth of the field (using WoS’ analyze functionality). We abbreviate the term Synthetic 
Biology referring to the set of articles retrieved by our query as SB. 
 
The most-active countries/regions over the period [2000 – 2013] are shown in Table 1. Recall 
that the WoS assigns an article to each country with at least one participating author as shown 
by the institutional address. Besides rankings over the whole period we also show number of 
publications and rankings for the first and the second half of the period. Moreover, we 
calculated the percentage of articles about synthetic biology among all articles (by that 
country, over the same period) and the ranking (restricted to the 20 countries/regions studied 
here) according to this parameter.  
 
Table 1. Most-active countries/regions over the period [2000 – 2013], data from the WoS. 
Rank Country # 
articles 
# publications and 
ranking [2000 – 2007] 
# publications and 
ranking [2008-2013] 
% SB among all 
articles and 
ranking 
1 USA 5973 2419 (1) 3554 (1) 0.144 (2) 
2 GERMANY 1392 504 (3) 888 (3) 0.129 (5) 
3 JAPAN 1294 630 (2) 664 (4) 0.125 (7) 
4 PEOPLES R 
CHINA 
1258 263 (5) 995 (2) 0.092 (13) 
5 ENGLAND 966 347 (4) 619 (5) 0.101 (12) 
6 FRANCE 621 244 (6) 377 (6) 0.080 (16) 
7 CANADA 553 224 (7) 329 (8) 0.088 (14) 
8 SOUTH KOREA 508 164 (9) 344 (7) 0.119 (8) 
9 ITALY 442 182 (8) 442 (10) 0.074 (17) 
10 SPAIN 410 128 (12) 282 (9) 0.083 (15) 
11 NETHERLANDS 385 164 (9) 221 (11) 0.110 (10) 
12 SWITZERLAND 346 143 (11) 203 (12) 0.136 (3) 
13 AUSTRALIA 301 109 (14) 192 (14) 0.069 (19) 
14 INDIA 300 105 (15) 195 (13) 0.069 (20) 
15 SWEDEN 279 110 (13) 169 (15) 0.113 (9) 
16 DENMARK 208 83 (16) 125 (18) 0.149 (1) 
17 ISRAEL 195 57 (18) 138 (17) 0.129 (4) 
18 TAIWAN 184 41 (19) 143 (16) 0.070 (18) 
19 SCOTLAND 158 35 (20) 123 (19) 0.106 (11) 
20 FINLAND 156 75 (17) 81 (20) 0.126 (6) 
 
China, South Korea and Taiwan moved up in the rankings when comparing the second period 
with the first one. Among the top countries Japan lost in the rankings. The ranking according 
to the percentage of articles devoted to Synthetic Biology shows that, on the one hand, 
Denmark, Israel and Finland have a high percentage of articles on SB. On the other hand 
China, although ranking second in the second period is only 13th in the ranking per 
percentage devoted to SB, illustrating the fact that China has many other priorities. Also 
Canada, France, Italy and Spain have other priorities. Compared with the results of Oldham et 
al. (2012) we notice several differences: UK is second in their core group, Switzerland 5th, 
Spain 6th, Japan 8th and China 10th. Yet, in the citing articles group China becomes 4th. 
Divided over continents Europe and North America have an equal share (37%), followed by 
Asia (22%), Latin America (2%) and Oceania (2%). Africa’s share is below 1%.  
 
Most active organizations are shown in Table 2. This list is clearly dominated by American 
universities. Yet, this list has no clear top university or small group of top organizations but 
numbers decrease slowly. We further note that the first company in this list is Genentech Inc. 
on rank 185 with 27 articles. This seems to indicate that, although synthetic biology can be 
considered an applied field it is not yet a field which is ripe for large scale commercialization.  
 
Table 2. Most-active organizations. 
Organization # articles 
MIT (USA) 244 
CHINESE ACAD SCI (P.R. China) 242 
HARVARD UNIV (USA) 242 
CALTECH (USA) 228 
STANFORD UNIV (USA) 221 
UNIV TOKYO (JPN) 203 
UNIV CALIF BERKELEY (USA) 197 
DUKE UNIV (USA) 148 
UNIV WASHINGTON (USA) 147 
UNIV ILLINOIS (USA) 138 
 
Again Oldham et al. (2012) obtain different results. Their list of most-active organizations 
consists of the University of California Berkeley, the Swiss Federal Institute of Technology 
(ETH), Harvard and MIT. We found 121 articles for ETH. Clearly, as already shown on 
country level, China and Japan are underrepresented in their investigation.  
 
Delving somewhat deeper into this we also performed a search for patents in the Derwent 
Innovations Index (DII), using a similar search query as in the WoS. Contrary to article 
publishing institutions, patent assignees are mostly Japanese and Korean. Yet numbers of 
assigned patents are an order of magnitude less than numbers of publications, affirming the 
observation that the field is not yet ripe for large-scale commercialization. 
 
Table 3. Most-active assignees (from the DII search). 
Assignee Name # patents 
CELLFREE SCI KK (=CO LTD) (JP) 25 
MACROGEN CO LTD (Korea) 23 
DOKURITSU GYOSEI HOJIN RIKAGAKU 
KENKYUSH (JP) 
17 
SHIMADZU CORP (JP) 17 
TOYOBOSEKI KK (JP) 17 
MASSACHUSETTS INST TECHNOLOGY (MIT) 
(USA) 
12 
NEC ELECTRONICS CORP (JP) 12 
UNIV LOUISIANA STATE & AGRIC & MECH 
COLL (USA) 
10 
RIKEN KK (JP) 10 
UNIV CALIFORNIA (USA) 9 
 
The multidisciplinary aspects of SB are clearly shown by the WoS categories involved in its 
research. Table 4 shows the top-5 categories. Also Oldham et al. (2012) have Biochemistry & 
Molecular Biology as leading subject category (core and citing articles), followed by 
Chemistry (for the citing articles group) and Biotechnology & Applied Microbiology (second 
in the core). Differences between our results and Oldham et al.’s or Goldman’s are due to the  
methodology. In particular, we used a more inclusive search query than our colleagues. 
 
Table 4. WoS categories most involved in SB research. 
WoS categories % of all articles 
BIOCHEMISTRY & MOLECULAR BIOLOGY 31.9 
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 21.7 
MULTIDISCIPLINARY SCIENCES 9.1 
BIOCHEMICAL RESEARCH METHODS 8.0 
MATHEMATICAL & COMPUTATIONAL BIOLOGY 6.7 
 
Research in SB is often supported by grants from large funding bodies. The WoS yields a list 
of 8,455 names, be it that there are many funds occurring under several names. Table 5 shows 
the most-important ones: NIH USA has more than 1000 supported articles, while the other 
ones have each at least 200 supported articles. 
 
Table 5. Most important funding organizations. 
National Institutes of Health (NIH) - USA 
National Science Foundation USA 
National (Natural) Science Foundation China 
European Union (EU) / European Commission (EC) 
Deutsche Forschungsgemeinschaft (DFG) 
 
Oldham et al.’s list of funding institutes is dominated by the NIH, NSF (USA) and the 
European Programs. Again, China’s research (funded by NSFC) is underrepresented.  
 
Doing better than evolution has a touch of “playing god” and certainly entails moral 
obligations and ethical problems. Adding the topic terms “ethic*”OR “moral*” to the main 
query led to 54 articles. The largest group (17) belongs to the WoS Category Ethics, followed 
by Social Sciences Biomedical (12). More than half were published in the latest two years. 
 
Growth in the number of articles on synthetic biology 
The yearly growth curve is shown in Figure 1. This curve can best be described as exponential 
growth. Giving the year 2000 the x-value 0 (and hence 2013 the x-value 13) a best-fitting 
curve is given by y = 454.3 e0.105x (R2 = 0.97), where y denotes the yearly number of 
published articles on SB.  
 
Figure 1. Growth in the number of published articles on SB. 
 
 
 
Topic keywords and year-based h-indices 
 
We found a total of 22,253 keywords (not including Keywords Plus, as these were generally 
too broad) in the retrieved records. However, the majority of them (76%) occurred just once, 
reflecting the broadness of the field, as well as the fact that, being in an emerging stage, 
terminology has not yet settled. Remarkably, the term synthetic biology (and related terms) 
occurred just 28 times (period 2000-2013) proving that we had to look into the field’s “world” 
rather than just considering the “word”. Focusing on major topics we brought keywords and 
related forms together under one name. In this way we obtained 35 high-frequent topic 
keywords each occurring at least 100 times. We removed general topics such as cell, enzyme, 
genetic, gene, protein, E. coli and their related terms, leading to 28 keywords, representing the 
hot topics in the field of SB. These keywords were analysed using a recently introduced 
approach based on year-based h-indices (Mahbuba & Rousseau, 2013). 
 
We recall the following definitions. Consider a given topic term T and assume that years (here 
restricted to the period 2000-2013) are ranked according to the number of articles published 
dealing with this topic. Then this topic’s year-based h-index is equal to t if t is the highest 
rank such that in the first t years t articles were published dealing with this topic. Let Z and Y 
be the latest and the oldest years included in the topic’s h-core, then the period [Y, Z] is called 
the core interval. If Z-Y+1 = t then there is no gap in the core. The core gap is defined as Z-
Y+1-t, or informally: the number of missing years in the core. Finally, the relative core gap 
for topic t is defined as: (core gap / t). In (Hu & Rousseau, 2014) we have shown how using 
these notions may provide an easy-to-use overview of a field. Table 6 shows the results of this 
analysis for the SB set. 
 
Table 6.  Hot topic keywords in the research field of synthetic biology and their year-based 
activity h-type indices (period 2000-2013). 
Topic keywords Year-based 
h-index 
Core 
interval Top year Core gap 
Relative 
core gap 
protein engineering 14 2000-2013 2011 0 0 
metabolic engineering 14 2000-2013 2013 0 0 
protein design+* 14 2000-2013 2012 0 0 
DNA+ 11 2002-2013 2013 1 0.09 
microRNA+ 10 2002-2013 2013 2 0.2 
cell-free protein synthesis+ 10 2004-2013 2007 0 0 
protein folding+ 10 2000-2011 2004 2 0.2 
RNA+ 9 2003-2013 2012 2 0.22 
mutagenesis+ 9 2004-2013 2002 1 0.11 
gene expression+ 9 2002-2013 2013 3 0.33 
stability+ 9 2004-2013 2013 1 0.11 
fluorescence+ 9 2001-2013 2013 4 0.44 
protein stability+ 9 2001-2013 2004 4 0.44 
gene regulatory network+ 8 2006-2013 2012 0 0 
directed evolution+ 8 2005-2013 2012 1 0.125 
nano+ 8 2005-2013 2013 1 0.125 
evolution+ 8 2003-2013 2013 1 0.125 
systems biology+ 8 2004-2013 2012 2 0.25 
microarray+ 8 2006-2013 2012 0 0 
sequential circuit+ 8 2000-2008 2000 1 0.125 
biocatalysis+ 7 2005-2013 2013 2 0.29 
combination+ 7 2002-2013 2013 5 0.71 
gene regulation+ 7 2005-2013 2013 2 0.29 
self-assembly+ 7 2007-2013 2012 0 0 
antibody+ 7 2002-2013 2013 5 0.71 
dynamics+ 7 2007-2013 2012 0 0 
protein-protein interaction+ 7 2006-2013 2013 1 0.14 
genome+ 6 2006-2013 2012 2 0.33 
*The symbol “+”indicates a keyword and its related terms 
 
Clearly, protein engineering, metabolic engineering and protein design are the overall hot 
topics in synthetic biology. Oldham et al. (2012) found the following top terms: synthetic 
biology, E. coli (a term we removed), gene expression, systems biology and metabolic 
engineering. Table 6 shows that the core interval of most topics extends to the latest year 
(2013). Moreover the top year (year in which the most articles on this topic were published) is 
often 2012 or 2013, indicating that the interest in these topics is still growing. Interest in 
sequential circuits seems to have passed its peak. We refer a more detailed discussion of the 
dynamics in the use of these topics to the conference presentation. 
 
Conclusion 
Clearly synthetic biology is one of the battlefields where the main countries fight for the 
supremacy in science (Joyce et al., 2013). The word “synthetic biology” hides a “big world”, 
ready to be explored by interdisciplinary research collaborations. We hope that our 
informetric study brings a new perspective to the study of this innovative field.  
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